MVP - Medical Developments International

[Joe Blow]

Medical Developments International Limited (MVP) is a healthcare company in pain relief and respiratory medicine. MDI has a range of products for pain management, asthma, oxygen delivery and veterinary use. The company consists of three major business divisions: Pharmaceutical; Medical Devices, and Veterinary.

http://www.medicaldev.com

 

[Country Lad]

Wow, not one post for this one which has been in uptrend since June 2010. Broke out again today. I hold.

Cheers
Country Lad

 

[skc]

Wow, not one post for this one which has been in uptrend since June 2010. Broke out again today. I hold.

Yes a very strong trend indeed. I bought some on open today. The market was slow to react to the positive announcement, but by the afternoon the sell depth is non-existence.

This is a case where we need some sellers to attract the buyers.

 

[Yacob]

MVP - Medical Developments Int.

Got in on these guys at 1.14 and 1.38. good future plans as well for growth, have been a nice stock for me so far, would recommend to anyone

 

[prawn_86]

Re: MVP - Medical Developments Int.

would recommend to anyone

Hi Yacob,

Welcome to ASF.

Can you elaborate as to why you would recommend this stock? WHat do you like about it in particular?

 

[piggybank]

It's a shame we no longer have Country Lad around anymore with his wonderful Point & Figure charts which I would love to emulate but I know I wasn't born with that talent unfortunately.

However this stick as been going gangbusters. In that since the beginning of the year the price as doubled from $3 to $6. Today's action saw it close up (2%) breaking out of an ascending triangle on increasing volume.

Please remember to do your own research prior to purchasing or selling shares

 

[Knobby22]

Nice rise today with the deal from China.
I bought some, sweated as they did a raising SPP buut now am comfortably on top as the price takes off.
I think its a long term buy. Government Bureaucracy is its problem. Funny how they can sell to Japan and New Zealand but have to wait for committees and rules etc. in Europe and especially in the USA.

 

[Knobby22]

A big jump today of 34c to $4.24.
Not sure why, maybe a deal being finalised in the USA?

 

[Knobby22]

Another big jump. Now $4.83. What is going on?

 

[Smurf1976]

Another big jump. Now $4.83. What is going on?

Not sure but I'm not complaining.

I hold.

 

[Knobby22]

Not sure but I'm not complaining.

I hold.

I doubled up recently at $3.76 but was (not now) underwater on my original buy.
I do think this company has a good future.

 

[Knobby22]

My pick for the month.
Green whistle now entering more markets. Hoping for a deal into the suss US markets which is the only country blocking it despite the many advantages with regard pain management and proven safety. Will require a US partner, the continuing price rise suggests one may be on the horizon.

 

[Knobby22]

Lower Aussie dollar and lower interest rates mean increased profits in a range of companies but this one may gain the most as manufacturing is in Australia and is expanding overseas.

 

[peter2]

Added some MVP to my portfolios today after yesterday's BO-NH.

 

[Knobby22]

eps increased from 0.41c to 1.61c.

Profit up 326.8% after tax.

Dividend 2c a share.

The rollout is just beginning. Surely 2.8c per share for the following year is reachable. when they get into the USA market, this will further increase earnings.

Cashflow is positive. Bank debt is practically zero.

I'm happy.

 

[sptrawler]

A very good full year report.

https://www.asx.com.au/asxpdf/20190925/pdf/448vph7p26txrn.pdf
Interesting the board members don't seem to be accumulating.

 

[Knobby22]

It's rising again so I am hoping it will continue to do so for the comp.
Hoping to hear some good news re: Penthrox.

 

[Trav.]

A nice positive announcment to start the day. It had a nice little rise yesterday 3.8% so as usual someone got in first.

Holding

https://www.asx.com.au/asxpdf/20191022/pdf/449qd1clg2qmr8.pdf

 

[Knobby22]

More good news, good to be in with MundiPharma.

Penthrox® entered in the European Society of Emergency Medicine (“EUSEM”) guidelines as now being recommended and approved as “first-line of treatment”

Medical Developments International Ltd (ASX: MVP) is delighted to announce that Penthrox has been

included in the new EUSEM guidelines for the “Management of acute pain in emergency situations”. These new guidelines are published on the EUSEM website and can be found

at: https://eusem.org/education/guidelines. The Guidelines cover all aspects of acute pain management in emergency situations across Europe.


Inclusion in these guidelines is a pivotal moment for Penthrox which is now a “first-line of treatment” option in both moderate and severe pain.


Clinical study data contained in the InMEDIATE and MEDITA studies is included within the guidelines providing clinical evidence supporting the Penthrox use. The Guidelines were sponsored financially by an educational grant from Mundipharma International Limited who had no editorial input.

 

[Knobby22]

Deal with China
New high.